OncoSec Medical to Present at the 2013 BIO International Convention on April 24

SAN DIEGO – April 17, 2013 — OncoSec Medical Inc. (OTCQB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced that Punit Dhillon, President and CEO, will present a company overview at the 2013 BIO International Convention. Mr. Dhillon’s presentation will take place on Wednesday, April 24, 2013 at 9:00 a.m. CT at the McCormick Place convention center in Chicago, IL.

About Bio International Convention 2013

Bio International Convention is the global event for the biotechnology industry attracting over 16,000 decision makers from 65 countries. The three-day event attracts thousands of companies from around the world and helps build strategic partnerships. BIO covers the wide spectrum of life science innovations and application areas. Drug discovery, biomanufacturing, genomics, biofuels, nanotechnology, and cell therapy are just a few of the industries represented at the BIO International Convention.

 

Punit Dhillon, President & CEO

Every day over 1,500 people in the US and an estimated 20,000 people around the world, just like you and me, will hear the news that they have been diagnosed with cancer. Thousands of them will be in the indication of melanoma or another lethal form of cancer. Those diagnosed with late stage cancer that has metastasized, or spread to other parts of the body, will have to face the difficult fact that there is less than 50% chance that they will survive more than 5 years with this disease.

With limited treatment options, these patients are in need of solutions now. These are not just statistics; I am constantly reminded of the urgency underlying our effort at OncoSec. We are focusing on developing novel therapies for the treatment of cancer, and to be successful, we are aware that we must be novel in our approach and to take advantage of tools that might not otherwise be traditionally used by companies in our space.

The emergence of digital-based social media has revolutionized our world. Like the Internet in the mid-1990′s and even the telephone and television before that, social media has changed the way we communicate and disseminate information. Today, information is abundant, and people are starved, to not only obtain, but also pass on this information to others. Because of this craving and its convergence with social media, we now think, see and react to events at a speed, and in ways, never before imagined, and this has affected all facets of our life, including health and medicine.

Now, doctors, pharmaceutical companies, advocacy groups, and patients have their own Facebook pages, Twitter accounts and blogs. A patient can post a question on a chat room about their disease and can expect an answer within hours, or even minutes, from a doctor or another patient from the other side of the world. Information fuels innovation, and as a company dedicated to being leaders in innovative ideas to treat cancer, we are obligated to take part in this social media revolution.

As President and CEO of OncoSec, I have the privilege of speaking with the leaders in the field of medical oncology on a daily basis. However, with the advent of social media and it’s complete integration into our daily lives, I realize that, although I have access to the state-of-the-art information as it pertains to medical oncology, it is only the tip of the iceberg. There is more to learn and gain from those waging the war against this terrible disease at the ground level; namely the doctors, patients and family members directly affected by cancer.

So today I join twitter as @PunitDhillon to become a part of the community willing to share their thoughts, insights, stories and beliefs about the urgency to mobilize the community at large to conquer cancer. My purpose is to gain access to the information in the ever-growing social-digital environment with the hope that I can help to build OncoSec into a stronger, more innovative and socially conscious organization.


Real Time Web Analytics